Hana Pharm Co Ltd (293480) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.005x

Based on the latest financial reports, Hana Pharm Co Ltd (293480) has a cash flow conversion efficiency ratio of -0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.41 Billion ≈ $-958.88K USD) by net assets (₩306.17 Billion ≈ $207.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 293480 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Hana Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Hana Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hana Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Advanced Analog Technology TWO:3438	0.009x
Nava Nakorn Public Company Limited BK:NNCL	0.023x
Southern Acids (M) Bhd KLSE:5134	0.068x
HusCompagniet AS CO:HUSCO	0.072x
Concorde International Group Ltd. NASDAQ:YOOV	N/A
BCnC Co. Ltd. KQ:146320	0.030x
Kino Polska TV SA WAR:KPL	0.086x
MODISON LIMITED NSE:MODISONLTD	0.021x

Annual Cash Flow Conversion Efficiency for Hana Pharm Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Hana Pharm Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 293480 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩309.18 Billion ≈ $209.52 Million	₩25.30 Billion ≈ $17.14 Million	0.082x	+23.60%
2023-12-31	₩277.98 Billion ≈ $188.39 Million	₩18.40 Billion ≈ $12.47 Million	0.066x	-42.46%
2022-12-31	₩268.40 Billion ≈ $181.89 Million	₩30.88 Billion ≈ $20.93 Million	0.115x	+12.98%
2021-12-31	₩251.90 Billion ≈ $170.71 Million	₩25.66 Billion ≈ $17.39 Million	0.102x	+51.91%
2020-12-31	₩232.38 Billion ≈ $157.48 Million	₩15.58 Billion ≈ $10.56 Million	0.067x	-53.43%
2019-12-31	₩220.33 Billion ≈ $149.32 Million	₩31.72 Billion ≈ $21.49 Million	0.144x	+7.17%
2018-12-31	₩205.39 Billion ≈ $139.19 Million	₩27.59 Billion ≈ $18.70 Million	0.134x	-56.98%
2017-12-31	₩81.30 Billion ≈ $55.09 Million	₩25.38 Billion ≈ $17.20 Million	0.312x	+38.97%
2016-12-31	₩55.48 Billion ≈ $37.60 Million	₩12.46 Billion ≈ $8.45 Million	0.225x	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$107.86 Million

₩159.16 Billion KRW

Market Cap Rank

#18992 Global

#906 in Korea

Share Price

₩9200.00

Change (1 day)

-0.65%

52-Week Range

₩8830.00 - ₩12430.00

All Time High

₩26028.86